Researchers in the United Kingdom have identified a drug that extends the lifespan of certain organisms by approximately 25 percent, marking a potential advance in the study of aging. The experimental compound, referred to as 991, was shown to increase longevity in yeast, worms, and flies by activating a protein known as AMP-activated protein kinase (AMPK).

AMPK plays a crucial role in cellular energy management, helping cells to conserve and generate energy during periods of stress, physical activity, or fasting. The activation of this protein has been linked to improved cellular function and resilience, which scientists have hypothesized may mitigate some of the biological effects associated with aging.

The research was conducted by the Redox Metabolism Group at the Medical Research Council and published in the journal Aging Cell. The study suggests that stimulating AMPK could harness the body’s natural survival mechanisms to promote longer lifespans in simple organisms. While the results currently apply only to model organisms, the researchers believe that understanding this pathway could open avenues for developing treatments that benefit human health and longevity in the future.

Further investigation is required to determine whether the effects observed in yeast, worms, and flies could be replicated safely and effectively in humans. Nonetheless, this discovery contributes to the growing body of research exploring how modulation of cellular energy processes might delay the aging process.